Advanced Research on Staphylococcus aureus

From pioneering infection diagnostics to innovative therapies, explore the latest advancements in Staphylococcus aureus research that drive precision in infection management.

Explore our preclinical study unveiling the potential of fully-human monoclonal antibody 1D9. Precision-designed to target the immunodominant staphylococcal antigen A (IsaA), offering promising therapeutic insights.

Dive into the potential of fluorescently labeled vancomycin (vanco-800CW) as a targeted tool for detecting Gram-positive bacterial infections. Explore innovative approaches to infection detection and diagnosis.